Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2003
11/13/2003WO2002079252A8 Isolated human transporter protein, nucleic acid molecules encoding human transporter protein, and uses thereof
11/13/2003WO2002079243A3 Gonococcal proteins and nucleic acids
11/13/2003WO2002079226A3 Isolated human lipase proteins, nucleic acid molecules encoding human lipase proteins, and uses thereof
11/13/2003WO2002076406A3 Antibodies against autoantigens of primary biliary cirrhosis and methods of making and using them
11/13/2003WO2002074905A3 Leptin induced genes
11/13/2003WO2002074903A3 Comparative mycobacterial geneomics as a tool for identifying targets for the diagnosis, prophylaxis or treatment of mycobacterioses
11/13/2003WO2002072888A3 Polymorphisms in the human cmoat gene and uses thereof
11/13/2003WO2002070699A3 Cofactors of the estrogen receptor alpha and methods of use
11/13/2003WO2002066681A3 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors
11/13/2003WO2002066648A3 Immunoglobulin superfamily variants expressed in mesenchymal cells and therapeutic uses thereof
11/13/2003WO2002064796A8 Butyrylcholinesterase polypeptide variants with increased catalytic efficiency and methods of use
11/13/2003WO2002063026A8 Complexes and components thereof for introducing polynucleotides into eukaryotic cells
11/13/2003WO2002061033A3 Transfection of human embryonic stem cells
11/13/2003WO2002057302A8 A virus causing respiratory tract illness in susceptible mammals
11/13/2003WO2002057290A8 Novel fibronectin epitopes and proteinaceous molecules capable of binding said epitopes
11/13/2003WO2002057226A8 68730 and 69112 protein kinase molecules and uses therefor
11/13/2003WO2002051992A9 21163, a novel human prolyl oligopeptidase and uses therefor
11/13/2003WO2002048339A3 Transgenic mice containing kir5.1 inwardly rectifying potassium channel gene disruptions
11/13/2003WO2002034909A3 Engineered chimera of hiv protein fragments and uses thereof
11/13/2003WO2002014551A9 Bioluminescent methods for direct visual detection of environmental compounds
11/13/2003WO2002014362A3 A hepatitis c virus non-structural ns3/4a fusion gene
11/13/2003WO2002014348B1 Glycoproteins and methods of use thereof
11/13/2003WO2001090419A9 Methods for genetic analysis of dna to detect sequence variances
11/13/2003WO2001090313A8 METHODS FOR ASSAYING GENE IMPRINTING AND METHYLATED CpG ISLANDS
11/13/2003WO2000021978A3 Laminin 5, 13 and 14 and uses thereof
11/13/2003US20030213018 Comprises polypeptide coding cis-zeatin O-glucosyltransferase for increasing cytokinin production in plants; plant bioengineering for increased crop production
11/13/2003US20030213017 Comprises nucleotide sequences coding enzymatic proteins associated with tocopherol biosynthesis; for nutritionally enhancing food and feed sources
11/13/2003US20030213016 Cyclin D polynucleotides polypeptides and uses thereof
11/13/2003US20030213015 Enhanced meristematic activity and competence by overexpression of tonoplast pyrophosphatase
11/13/2003US20030213013 Fructose polymer synthesis in monocot plastids
11/13/2003US20030213011 Killing or slowing the growth of plant insect pest or larva using over expression of biotin binding protein; insecticidal proteins; pesticides; biological pest control
11/13/2003US20030213010 Comprises nucleotide sequences coding anthranilate synthase for increasing tryptophan concentration in animal feeds and human foods
11/13/2003US20030213009 Comprises regulatory sequences of actin deploymerizing factor (ADF) for controlling trangene expression in plants; gene expression inhibition
11/13/2003US20030213008 Method to produce cloned embryos and adults from cultured cells
11/13/2003US20030213006 Nucleotide sequences comprised of human chorionic gonadotropin (HCG) regulatory sequences for treating and preventing tumors via gene expression inhibition; drug screening
11/13/2003US20030213005 Genetically engineered nonhuman animal model coding lethal alleles which function in controlling the population of transgenic animal
11/13/2003US20030213004 Composition comprising ribozyme/monoclonal antibody fusion protein for treating cell proliferative disorders; anticarcinogenic/antiproliferative agents
11/13/2003US20030213003 Preparing and recoverng genetically engineered fusion protein for treating diabetes
11/13/2003US20030212455 Identification of in vivo dna binding loci of chromatin proteins using a tethered nucleotide modification enzyme
11/13/2003US20030212267 Synthesis of sulfurized oligonucleotides
11/13/2003US20030212266 Growth arrest homeobox gene
11/13/2003US20030212265 Detection using genetic engineered nucleic acid
11/13/2003US20030212264 Pancreatic cancer genes
11/13/2003US20030212262 Human serine racemase
11/13/2003US20030212259 Recombinant photoproteins and their conjugates
11/13/2003US20030212255 Novel proteins and nucleic acids encoding same
11/13/2003US20030212252 Comprises g-protein coupled receptor polypeptide, melanin-concentrating hormone receptor (MCH) for treating hypertension, diabetes, cancer, dyslipidemias, cardiovascular disease, gall stones and osteoarthritis
11/13/2003US20030212132 Determination binding of gabapentin to cells
11/13/2003US20030212032 Oligonucleotide N3'→P5' thiophosphoramidates: their synthesis and use
11/13/2003US20030212031 Stable lipid-comprising durg delivery complexesand methods for their production
11/13/2003US20030212030 Blood disorders; synergistic mixture of vector and monoclonal antibody
11/13/2003US20030212026 Induce immunology response
11/13/2003US20030212024 Compositions and methods for cell dedifferentiation and tissue regeneration
11/13/2003US20030212023 Invention provides cDNAs encoding deoxyribonuclease II beta and isolated, purified deoxyribonuclease II beta proteins and antibodies against this protein and antisense agents targeted to cDNA or mRNA encoding deoxyribonuclease II beta
11/13/2003US20030212020 Antisense modulation of macrophage migration inhibitory factor expression
11/13/2003US20030212019 Hybrid nucleic acid; anticancer agents
11/13/2003US20030211997 Mimetic peptides for an epitope of apolipoprotein B-100, concatemers of the peptides, and modified peptides, and compositions comprising the same
11/13/2003US20030211996 Virus like particles
11/13/2003US20030211990 Central nervous system disorders; test kits
11/13/2003US20030211985 Binding to antibody; bactericides
11/13/2003US20030211984 Genetic engineering; antibodies; libraries
11/13/2003US20030211970 Processing of plasmid-containing fluids
11/13/2003US20030211968 Neuromedin u receptor nmur2 and nucleotides encoding it
11/13/2003US20030211615 System for detection of a functional interaction between a compound and a cellular signal transduction component
11/13/2003US20030211614 Using genetically engineered adeno-associated viral vector to transfer hereditary material into cells; gene therapy
11/13/2003US20030211613 Methods of altering calcium transport
11/13/2003US20030211612 Establishment of cellular manipulations which enhance oligo-mediated gene targeting
11/13/2003US20030211611 Antisense modulation of estrogen receptor alpha expression
11/13/2003US20030211610 Comprises oligonucleotide for suppressing activity of a disintegrin and metalloproteinase (ADAM) enzyme and treating osteoarthritis, inflammation and blood disorders; gene expression inhibition
11/13/2003US20030211608 Antisense modulation of glycogen synthase kinase 3 beta expression
11/13/2003US20030211607 Antisense modulation of survivin expression
11/13/2003US20030211599 Miniature achromosomal and anucleate cell for use as drug delivery system; antitumor/antiproliferative agents
11/13/2003US20030211598 Administering antitumor agents to tissues having an epithelial membrane; drug delivery; gene therapy
11/13/2003US20030211593 Comprises polymerase with modified exonuclease activity for use as amplification tool in DNA replication reactions
11/13/2003US20030211590 Fusion protein comprising cold shock domain and translocation sequences for delivery of nucleic acids into cell or nucleus in vitro and/or in situ; gene therapy; animal models
11/13/2003US20030211583 Egs molecules that specifically downregulae bcl-xl experession
11/13/2003US20030211581 Comprises nucleotide sequences coding genetic suppressor elements/transcription control elements; regulatory sequences; gene expresson inhibition
11/13/2003US20030211579 Methods for increasing polypeptide production
11/13/2003US20030211577 Novel G protein-coupled receptor, GAVE7
11/13/2003US20030211573 Preparing glycoprotein in cells using enhanced carbamoyl-phosphate synthase II (CPS II)/aspartate transcarbamoylase (ATCase)/dihydro-orotase (CAD) enzyme; drug delivery and design
11/13/2003US20030211571 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chrondrocytes by contacting blood with polypeptide; cancer diagnosis
11/13/2003US20030211570 Comprises nucleotide sequences coding membrane protein for use in treatment of tumors and cell proliferative diseases; antiinflammatory agents
11/13/2003US20030211567 Compositions, methods and systems for discovery of lipopeptides
11/13/2003US20030211563 Human testis specific serine/threonine kinase 1 & 2
11/13/2003US20030211561 Human oxalyl-CoA decarboxylase
11/13/2003US20030211559 Comprises composition for identifying therapeutic agents that inhibit proteolytic processing of amyloid precursor protein; treating nervous system disorders
11/13/2003US20030211552 Cyclic GMP dependent protien kinase as a chemotherapeutic target for antiprotozoal agents
11/13/2003US20030211546 Identifying bioactive agent/enzyme inhibitors capable of interfering with the binding of protein phosphatase 5 (PP5) to RAD protein; antitumor agents
11/13/2003US20030211543 Screening clone pools for DNA sequences associated with preferential enzymatic activities
11/13/2003US20030211541 Using immunological means to identify growth differentiation factor-14 (GDF-14) for treating cell proliferative and immunological disorders; gene expression inhibition; antiproliferative agents
11/13/2003US20030211540 Treatment of insulin resistance
11/13/2003US20030211535 Bi-directionally cloned random cDNA expression vector libraries, compositions and methods of use
11/13/2003US20030211533 Method for testing a therapeutic or preventive agent for hyperlipidemia
11/13/2003US20030211531 Methods for discovering tumor biomarkers and diagnosing tumors
11/13/2003US20030211530 Developing receptor tyrosine kinase targeted antitumor regimen; anticarcinogenc agents
11/13/2003US20030211529 Human Eag2
11/13/2003US20030211527 Internal positive control for probe-based nucleic acid molecule assays and methods of making and using thereof
11/13/2003US20030211522 Methods for fetal DNA detection and allele quantitation
11/13/2003US20030211521 Breast cancer antigen
11/13/2003US20030211520 Comprises urogenital system specific protein for diagnosing and treating tumors; antiproliferative agents; genetic vaccine
1 ... 2376 2377 2378 2379 2380 2381 2382 2383 2384 2385 2386 2387 2388 2389 2390 2391 2392 2393 2394 2395 2396 ... 4023